Esperion Therapeutics
ESPR
#6513
Rank
โ‚น75.93 B
Marketcap
โ‚น294.66
Share price
0.00%
Change (1 day)
37.04%
Change (1 year)

EPS for Esperion Therapeutics (ESPR)

EPS in 2026 (TTM): -โ‚น1.94

According to Esperion Therapeutics's latest financial reports the company's current EPS (TTM) is -โ‚น1.85. In 2025 the company made an earnings per share (EPS) of -โ‚น12.05 an increase over its 2024 EPS that were of -โ‚น21.31.

EPS history for Esperion Therapeutics from 2014 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-โ‚น1.94-83.92%
2025-โ‚น12.05-43.48%
2024-โ‚น21.31-89.15%
2023-โ‚น196.44-40.28%
2022-โ‚น328.94-62.87%
2021-โ‚น885.8380.38%
2020-โ‚น491.1050.14%
2019-โ‚น327.09-53.18%
2018-โ‚น698.667.41%
2017-โ‚น650.47110.81%
2016-โ‚น308.5647.35%
2015-โ‚น209.410.89%
2014-โ‚น207.56

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
โ‚น65.79-3,650.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
โ‚น4,353-235,000.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
-โ‚น480.91 25,850.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
-โ‚น12.97 600.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
-โ‚น10.19 450.00%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
-โ‚น8.34 350.00%๐Ÿ‡บ๐Ÿ‡ธ USA